Skip to content

Reduce infection risk and maintain compliance

What are ambulatory surgery centers? (ASC)

The ASC space has grown rapidly in recent years and is expected to reach $58.85 billion by 2028.1

This growth is largely driven by the shift of many procedures—previously performed in traditional hospital settings—now shifting to ASCs.1

One of the key contributing factors to this migration is that ASCs can largely perform the same procedures as hospitals for about half the cost with equal, if not better, clinical outcomes.

HemoCue® Glucose 201 Systems are ideal solutions for ASCs with a goal to promote surgical readiness, reduce deferrals, and lower infection risk while maintaining regulatory compliance.

Want to learn more about how point-of-care testing can be the ideal solution for ASCs with the goal to improve patient care?

Contact us

Expand glucose testing
to all your surgical patients

Over 20% of diabetes cases and over 80% of prediabetes cases are undiagnosed in the US.2

By implementing reliable glucose testing as part of your preoperative assessment may help improve outcomes for your general surgery population, not only those diagnosed with diabetes.

HemoCue® Glucose 201 Systems offer a quick and reliable system to test patient glucose levels at the point of care (POC).​

With POC testing, patients can have diagnostic tests performed at an ASC, immediately discuss the implications of the results on surgery suitability, help avoid unnecessary surgery cancellations, and enable rapid clinical decision-making.

 

HemoCue solutions for ASCs

The HemoCue® Glucose 201 Systems was developed specifically for use by healthcare professionals testing patients to validate glucose levels for a broader patient population. These lab quality values are critical to ASC’s for patient eligibility for surgery to promote the best patient outcomes.

With individual microcuvettes, HemoCue reduces the risk of blood testing cross contamination.

HemoCue helps ASCs maintain regulatory compliance with The Joint Commission and other ASC regulatory bodies with solutions indicated for known uses within surgery centers.

Contact us to learn more

Continuing education seminar

CE program sponsored by HemoCue (complementary)

The United States (US) is facing a public health crisis: the escalating diabetes epidemic and its profound impact on individuals, families, and the health care system.

In 2021, 38.4 million people had diabetes, a figure that excludes the substantial number of undiagnosed cases.3 Given the high prevalence of undiagnosed diabetes and prediabetes, integrating a standardized glucose testing program into preoperative assessments could enhance surgical outcomes, benefiting not only patients with known diabetes but the broader surgical population. 

This program will delve into the types and mechanisms of glucose testing systems, the importance of compliance, and the best practices for infection control in ambulatory settings. By understanding these elements, health care providers (HCPs) can better support their patients while minimizing the risk of infections. Through education, training, and adherence to established guidelines, we can ensure that glucose testing is both accurate and safe, ultimately leading to better health outcomes for patients. 

 

Click here to schedule a CE seminar

Learning objectives

After completing this continuing education activity, the participant should be able to:

Examine the various blood glucose monitoring (BGM) devices and explain the underlying mechanisms of glucose measurement.

Discuss the importance of adherence to regulatory guidelines and assess the impact of compliance with institutional policies on patient safety, clinical outcomes, and the prevention of adverse events related to glucose monitoring.

Identify potential risks of bloodborne pathogen transmission and understand strategies to mitigate infection risks when performing glucose monitoring in the ambulatory care setting.

Intended audience need

This continuing education activity is intended for a registered nurse, surgical technologist, or other healthcare professional who wants to learn more or needs to gain knowledge and skills in glucose testing.

Teaching methodologies 

This continuing education activity is governed by principles of adult learning. PowerPoint images will be used to augment the speaker’s presentations and a supportive study guide with content and references is provided to each participant. Attendees will have an active role in discussion as well as opportunities to ask questions and share experiences.

Steps for successful course completion

To earn continuing education credit, the participant must complete the following steps:

Upon course completion of the above requirements, a Certificate of Attendance is awarded. This Certificate is found in your MyLearning profile on the Pfiedler Education website.

Attend the presentation and log into the course link provided to access materials.

Review the learner objectives, course content, and post-test.

Access the evaluation in the menu and finish the course evaluation to receive credit for this activity.

HemoCue® Glucose 201 System

The HemoCue® Glucose 201 System provides lab-quality results at the point of care. Accuracy established with a laboratory-based reference method. Provides reliable test results in CLIA-waived settings.

HemoCue® Glucose 201 System
Factory calibrated and traceable to the ID GC-MS* lab method, which fulfills all requirements to be used in a higher-order reference measurement procedures.4 AMA approved for use with reimbursable CPT codes.

For professional use only and can be used for patients at risk for diabetes.

Explore our glucose solutions and discover how HemoCue can support your diagnostic needs with accuracy and reliability.

 

Go to the product page to learn more

Our service
and support

HemoCue OnCue™ Education

HemoCue OnCue™ Support is a comprehensive program designed to meet your needs as quickly and conveniently as possible. Powered by HemoCue employees, you get answers and education from the experts who know our products best.  OnCue™ Education, an integral part of HemoCue OnCue™ Support, is a series of on-demand, e-learning modules designed to ensure your team is trained on the basics of system use, specimen collection, and product maintenance.

Provide your staff access to training on HemoCue products (hematology systems, diabetes management, and more)

• Receive automatic reminders for certification renewal of operators

• Download or print completion certificates

• Certify additional users as needed

Learn more here

Our Accuracy

The HemoCue® Glucose 201 System has demonstrated high accuracy when compared to other central laboratory instruments. According to the HemoCue® Glucose 201 Systems Performance Report, its performance aligns closely with both Roche and Abbott central lab analyzers.5

Accuracy against Abbott ARCHITECT ci8200

120 venous blood samples were collected and analyzed in duplicate with HemoCue® Glucose 201 System and in single with the ARCHITECT ci8200

Note the R value on the chart (r = 0.994), this value indicates the correlation between the Glucose 201 and the Abbott instrument, 0.994 is equivalent to 99.4% correlation.

Accuracy against Roche Cobas Modular

129 venous blood samples were collected and analyzed in duplicate with both methods

Each blood sample was divided in two portions: one for analysis with the HemoCue® Glucose 201 System and one for the comparative method

Note the R value on the chart (r = 0.996), this value indicates the correlation between the Glucose 201 and the Roche instrument, 0.996 is equivalent to 99.6% correlation.

Frequently asked
questions

Labeled for professional use only, these diagnostic tools are AMA approved for use with multiple CPT codes.

You can find instructional videos for all systems at our HemoCue OnCue™ Support 

More than 3,000 publications include testing with HemoCue® Hemoglobin Systems. Approximately 20 million HemoCue tests were performed on patients in the US alone in 2024 with 11,000+ clinician practices and labs. These figures are based on internal data.

References

1 https://www.iqvia.com/locations/united-states/blogs/2024/03/expanding-business-into-ambulatory-surgery-centers

2 https://www.cdc.gov/pcd/issues/2023/23_0173.htm​

3 https://www.cdc.gov/diabetes/php/data-research/?CDC_AAref_Val=https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf

4 Andreis E, Küllmer K, Appel M. Application of the reference method isotope dilution gas chromatography mass spectrometry (ID/GC/MS) to establish metrological traceability for calibration and control of blood glucose test systems. J Diabetes Sci Technol. 2014 May;8(3):508-15. doi: 10.1177/1932296814523886. Epub 2014 Feb 21. PMID: 24876614; PMCID: PMC4455442.​

5 HemoCue® Glucose 201 Systems Performance Report Glucose 201